CEFODIZIME (THR-221) IN URINARY TRACT INFECTIONS

We administered cefodizime (THR-221), a new synthetic cephalosporin antibiotic, to 8 patients with complicated urinary tract infection and lwith acute pyelonephritis. Clinical evaluations were made in the 8 patients with complicated urinaly tract infection according to the UTI criteria, as excellent...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 36; no. Supplement5; pp. 742 - 746
Main Authors SUZU, HIROSHI, JODAI, AKIHITO, KOGA, NARUHIKO, MINAMI, YUZO, MATSUO, FUKUZO, KIYOHARA, TATSUO, YUSHITA, YOSHIAKI, SAKURAGI, TSUTOMU, KANETAKE, HIROSHI, SHINDO, KAZUHIKO, SAITO, YUTAKA, WATANABE, YOSHIHIRO
Format Journal Article
LanguageEnglish
Japanese
Published Japanese Society of Chemotherapy 1988
Online AccessGet full text

Cover

More Information
Summary:We administered cefodizime (THR-221), a new synthetic cephalosporin antibiotic, to 8 patients with complicated urinary tract infection and lwith acute pyelonephritis. Clinical evaluations were made in the 8 patients with complicated urinaly tract infection according to the UTI criteria, as excellent in 1 patients, moderate in 2 and poor in 5 patients. Clinical evaluation in 1 patient with acute pyelonephritis was moderate. No side-effects were observed in any of the cases, though elevation of eosinophils and mononuclear leukocytes were observed in 1 case.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.36.Supplement5_742